Higher HbA1c may reduce axial length elongation in myopic children: a comparison cohort study

Chun-Fu Liu1,2,3, Shin-Chieh Chen1,3,4, Kuan-Jen Chen3,4

  • 1Department of Ophthalmology, Chang Gung Memorial Hospital, Keelung, Taiwan.

Acta Diabetologica
|February 15, 2021
PubMed

Insights

Children with type 1 diabetes mellitus (T1DM) experienced slower axial length elongation compared to non-diabetic peers. Higher HbA1c levels were linked to reduced myopia progression in T1DM patients.

Area of Science:

  • Ophthalmology
  • Endocrinology
  • Pediatrics

Background:

  • Myopia progression is a significant concern in children.
  • Type 1 diabetes mellitus (T1DM) is a chronic condition affecting various bodily systems.
  • The impact of T1DM on refractive error development, specifically axial length changes, requires further investigation.

Purpose of the Study:

  • To compare annual axial length (AL) changes in myopic children with T1DM versus those without diabetes.
  • To identify factors influencing AL elongation in myopic children with T1DM.

Main Methods:

  • Retrospective cohort study comparing two groups of myopic children (T1DM vs. non-diabetic).
  • Analysis of baseline clinical characteristics and annual AL changes.
  • Generalized Estimating Equations (GEE) model to determine contributing factors.

Main Results:

  • Myopic children with T1DM exhibited significantly slower annual AL changes (50.5% slower) and shorter baseline AL compared to the non-diabetic group.
  • The average age of participants was approximately 14.7 years.
  • Serum glycated hemoglobin (HbA1c) level was identified as the most significant factor in reducing AL elongation in the T1DM group.

Conclusions:

  • Elevated long-term HbA1c levels may be associated with reduced axial length elongation in myopic children with T1DM.
  • Implementing strict blood sugar control strategies is crucial for managing myopia progression in children with T1DM.
Abstract

Related Concept Videos